Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China

Abstract

The impact of heart failure (HF) on acute myocardial infarction (AMI) in patients from southwestern China remains unclear. The present study aimed to compare in-hospital cardiovascular events, mortality and clinical therapies in AMI patients with or without HF in southwestern China. In total, 591 patients with AMI hospitalized between February 2009 and December 2012 were examined; those with a history of HF were excluded. The patients were divided into four groups according to AMI type (ST-elevated or non-ST-elevated AMI) and the presence of HF during hospitalization. Clinical characteristics, in-hospital cardiovascular events, mortality, coronary angiography and treatment were compared. Clinical therapies, specifically evidence-based drug use were analyzed in patients with HF during hospitalization, including angiotensin converting enzyme inhibitors (ACEIs) and β-blockers (BBs). AMI patients with HF had a higher frequency of co-morbidities, lower left ventricular ejection fraction, longer length of hospital stay and a greater risk of in-hospital mortality compared with AMI patients without HF. AMI patients with HF were less likely to be examined by cardiac angiography or treated with reperfusion therapy or recommended medications. AMI patients with HF co-treated with ACEIs and BBs had a significantly higher survival rate (94.4 vs. 67.5%; P<0.001) compared with untreated patients or patients treated with either ACEIs or BBs alone. Logistic regression analysis revealed that HF and cardiogenic shock in patients with AMI were the strongest predictors of in-hospital mortality. AMI patients with HF were at a higher risk of adverse outcomes. Cardiac angiography and timely standard recommended medications were associated with improved clinical outcomes.

Inositol pyrophosphates mediated the apoptosis induced by hypoxic injury in bone marrow-derived mesenchymal stem cells by autophagy

“…Although the treatment of coronary heart disease has made rapid progress, ischemic heart disease induced by coronary artery occlusion is a key cause of morbidity and mortality around the world [1][2][3][4]. At present, treatment with stem cell has a potential effect on cardiovascular regeneration of ischemic heart disease.…”

In-Hospital Mortality in Patients With Acute ST-Elevation Myocardial Infarction With or Without Mitral Regurgitation

“…A long-term follow-up study revealed that mortality varies according to Killip class, where class 1 had 17.7%, class 2 had 27.3%, class 3 had 30.4%, and class 4 had 48.5% mortality [ 16 ]. This trend indicates that these patients commonly develop pulmonary complications, especially pulmonary edema and congestion, which contribute to the increased mortality rates [ 17 ].…”

Clinical pharmacist intervention reduces mortality in patients with acute myocardial infarction: a propensity score matched analysis

“…20 In addition, logistic regression analysis was performed using a backward selection model in the following order: (1) the presence of clinical pharmacists' interventions; and (2) risk factors including age, gender and CCI. 21 Dichotomous variables were expressed as counts (percentage) and were analysed using the χ 2 test or Fisher's exact test. Continuous variables are presented as mean (SD) and were tested using a grouped t test or Wilcoxon rank sum test.…”